Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Sale |
2025-04-03 4:30 pm |
NEVRO CORP | NVRO | Prange Karen Director |
33,948 | $0 | $0 | 0 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 08:21 am |
AtriCure Inc. | ATRC | Prange Karen Director |
6,100 | $38.12 | $232,532 | 17,828 (Direct) |
View |
| 2023-07-19 Sale |
2023-07-21 4:02 pm |
ViewRay Inc. | VRAY | Prange Karen Director |
129,466 | $0.06803 | $8,808 | 8,799 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 08:59 am |
AtriCure Inc. | ATRC | Prange Karen Director |
713 | $47.89 | $34,146 | 16,140 (Direct) |
View |
| 2022-05-10 Purchase |
2022-05-12 06:05 am |
ViewRay Inc. | VRAY | Prange Karen Director |
37,600 | $2.6596 | $100,002 | 83,754 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-02 5:27 pm |
CANTEL MEDICAL CORP | CMD | Prange Karen Director |
1,935 | $80.59 | $155,942 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 6:26 pm |
N/A N/A |
Embecta Corp. | EMBC | Prange Karen Director |
13,839 | $0 | 39,743 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 6:55 pm |
N/A N/A |
NEVRO CORP | NVRO | Prange Karen Director |
19,169 | $0 | 33,948 (Direct) |
View |
| 2024-05-13 Option Award |
2024-05-14 5:04 pm |
N/A N/A |
AtriCure Inc. | ATRC | Prange Karen Director |
7,788 | $0 | 23,928 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:08 pm |
N/A N/A |
Embecta Corp. | EMBC | Prange Karen Director |
11,455 | $0 | 24,898 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:15 pm |
N/A N/A |
NEVRO CORP | NVRO | Prange Karen Director |
6,754 | $0 | 14,779 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 4:25 pm |
N/A N/A |
AtriCure Inc. | ATRC | Prange Karen Director |
3,186 | $0 | 16,853 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 4:09 pm |
N/A N/A |
Embecta Corp. | EMBC | Prange Karen Director |
6,979 | $0 | 13,069 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:09 pm |
N/A N/A |
ViewRay Inc. | VRAY | Prange Karen Director |
54,511 | $0 | 138,265 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 8:59 pm |
N/A N/A |
NEVRO CORP | NVRO | Prange Karen Director |
4,155 | $0 | 8,025 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-27 09:03 am |
N/A N/A |
AtriCure Inc. | ATRC | Prange Karen Director |
3,564 | $0 | 13,667 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 5:38 pm |
N/A N/A |
Embecta Corp. | EMBC | Prange Karen Director |
6,024 | $0 | 6,024 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 4:32 pm |
N/A N/A |
ViewRay Inc. | VRAY | Prange Karen Director |
26,395 | $0 | 46,154 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 4:25 pm |
N/A N/A |
ViewRay Inc. | VRAY | Prange Karen Director |
19,759 | $0 | 19,759 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-26 9:01 pm |
N/A N/A |
NEVRO CORP | NVRO | Prange Karen Director |
1,167 | $0 | 3,870 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:52 pm |
N/A N/A |
AtriCure Inc. | ATRC | Prange Karen Director |
1,749 | $0 | 10,103 (Direct) |
View |
| 2020-07-31 Option Award |
2020-07-31 5:53 pm |
N/A N/A |
CANTEL MEDICAL CORP | CMD | Prange Karen Director |
1,935 | $0 | 1,935 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 08:28 am |
N/A N/A |
AtriCure Inc. | ATRC | Prange Karen Director |
2,452 | $0 | 8,354 (Direct) |
View |